TrialJournal of clinical hypertension (Greenwich, Conn.)2004

Efficacy and safety of the selective aldosterone blocker eplerenone in Japanese patients with hypertension: a randomized, double-blind, placebo-controlled, dose-ranging study.

Takao Saruta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.